Abstract
Synthesis and catalytic activity of chiral ligands 5,6-diphenyl-3-{3-[(4S/R)-4-R/Ar-4,5-dihydro-1,3-oxazol-2-yl]pyridin-2-yl}amino-1,2,4-triazines 2 and their analogs 3 possessing an N-oxide function in the pyridine ring are described. The pivotal step in the synthesis of ligands 2 is the Buchwald-Hartwig Pd-catalyzed cross-coupling reaction between 3-bromo-5,6-diphenyl-1,2,4-triazine (7a) and enantiopure 3-(4,5-dihydro-1,3-oxazol-2-yl)pyridin-2-amines 6a–d. Aromatic nucleophilic substitution of chlorine in 3-chloro-5,6-diphenyl-1,2,4-triazine (7b) with 3-(4,5-dihydro-1,3-oxazol-2-yl)pyridin-2-amine 1-oxides 12 was investigated as the key reaction in the synthesis of ligands 3. Two undesired derivatives 13 or 14, resulting from unexpected reactions of 3, were isolated depending on reaction conditions. Compounds 2 and 3 as well as the side products 13 and 14 were screened as chiral ligands in the copper catalyzed enatioselective nitroaldol reaction.
Introduction
According to our interest focusing on the design, synthesis, and applications of chiral oxazoline ligands we have already described several ligands 1 which combine in their structure two heterocyclic moieties: chiral oxazoline and 1,2,4-triazine linked by an N-phenylamine unit (Figure 1). The ligands differ in the type of a substituent in the oxazoline ring and in the substitution mode of the 1,2,4-triazine moiety.

Previously investigated 1,2,4-triazine-oxazoline ligands.
These ligands were applied to the copper catalyzed enantioselective nitroaldol reaction of several aromatic and aliphatic aldehydes providing products with enantiopurity up to 92% and yield up to 95% [1–3]. Thus, the ligands with the phenyl substituent in the oxazoline ring and ligands that possess the indane moiety exhibit high stereocontrolling abilities. Substitution in the 1,2,4-triazine ring has a crucial impact on chemical yield of the investigated reaction. From this point of view, the ligands having a phenyl group at the C5 position of 1,2,4-triazine are preferred. Structures of 1-Cu complexes so far are not known, but it can be suggested on the basis of the ligand crystal structures [4] that the nitrogen atoms of oxazoline and amino groups may participate in the complexation of copper ion. Similar complexation mode of zinc was observed by Guiry [5]. In the Henry reaction, a base or counter ion is necessary to abstract the proton from nitromethane. Our catalytic system works without an external base, so the nitronate anion must be generated with the involvement a counter ion or the 1-Cu complex plays the role of a bifunctional catalyst. As an extension of the previous work, now we report the synthesis of chiral oxazoline ligands 2 and 3 as analogs of ligands 1 where the N-phenylamine linkage is replaced with pyridine-2-amine or 2-aminopyridine 1-oxide moiety (Figure 2). The presence of the nitrogen atom or N-oxide moiety in the linkage can change electronic properties of the donating nitrogen atoms, thus having impact on the complexation and stereo-controlling abilities of ligands. They can also act as an additional internal base. On the other hand, the competition between the new electron pair donors and the nitrogen atoms of oxazoline and amino groups in complexation with copper ion can take place.

Chiral oxazoline ligands with six-membered azaheteroaromatic rings.
Results and discussion
The 1,2,4-triazine ring is π-electron deficient and, therefore, susceptible to nucleophilic attack [6]. Highly active 3,3′-dichloro-5,5′-bi-1,2,4-triazine undergoes displacement of chlorine atoms after few minutes of stirring with aliphatic amines or aniline in the absence of an additional base [7]. Reactions of less active 1,2,4-triazines require the presence of metal catalyst to replace halogen or other nucleofugal leaving group [1, 8, 9]. Thus, a two-step synthetic route to ligands 2 employs the Pd-catalyzed Buchwald-Hartwig reaction [10–14] of enantiopure 3-(4,5-dihydro-1,3-oxazol-2-yl)pyridin-2-amines 6 with 3-bromo-5,6-diphenyl-1,2,4-triazine (7a) as the key step (Scheme 1). 3-(4,5-Dihydro-1,3-oxazol-2-yl)pyridin-2-amines 6a–d were obtained by condensation of enantiomerically pure aminoalcohols 5a–d with the cyano group of 2-aminopyridine-3-carbonitrile (4). This reaction was conducted in the presence of a catalytic amount (20 mol%) of ZnCl2 as Lewis acid [15]. After 4 days of heating in boiling chlorobenzene the appropriate (oxazol-2-yl)pyridin-2-amines 6a–d were isolated with 31–99% yield. Our previously described protocol of condensation of aminoalcohols with 2-aminobenzonitrile requires the use of an excess of ZnCl2, and after removal of solvent, stirring the mixture with NaOH solution to isolate the product [1]. The use of three-fold excess of ZnCl2 in the reaction between 4 and 5a–d allowed to shorten the reaction time to 24 h, but isolation of the product from the reaction mixture appeared difficult.

Synthesis of ligands 2a–d.
After obtaining amines 6, an attempt to react them with 3-bromo-5,6-diphenyl-1,2,4-triazine (7a) was undertaken. To synthesize the ligands 2a–d the application of Buchwald-Hartwig Pd-catalysis was necessary. Thus, the aryl aminations between 7a and 6a–d were carried out using Pd2dba3, Xantphos, and K2CO3 in boiling dioxane (Scheme 1). This procedure allowed to obtain the ligands 2a–d in moderate yields ranging from 32% to 37%.
Synthesis of ligands of type 3 could not be accomplished by simple oxidation of 2a–d, since 1,2,4-triazine [16] as well as the oxazoline [17] rings are also susceptible to oxidizing conditions. Initial attempt was made to obtain ligands 3 utilizing amination of 3-halo-1,2,4-triazine with N-protected aminopyridine 1-oxides 9 based on aza-Smiles rearrangement (Scheme 2) [18].

Proposed synthetic approach to ligands 3.
Analogous protocol described by us previously, proved to be effective for amination of pyridine and pyrimidine halides [18, 19]. This approach assumes formation of intermediary salt 10 in reaction of formamidine protected 2-aminopyridine-3-carbonitrile 1-oxide 9 with 3-chloro-5,6-diphenyl-1,2,4-triazine (7b). Base-induced rearrangement of 10 should give derivative 11, the condensation of which with aminoalcohols 5 would produce ligands 3. A reaction of N-oxide 8 with 3 equivalents of N,N-dimethylformamide dimethyl acetal (DMF-DMA) was carried out at room temperature without any solvent. After 80 h of stirring, the amidine protected compound 9 was isolated in 92% yield. To our disappointment, the next step, the preparation of salt 10 appeared difficult. A typical procedure for amination of pyridine and pyrimidine halides with formamidine protected aminopyridine 1-oxides involving stirring of the substrates in dry DMF at room temperature in the case of 1,2,4-triazine halide proved to be ineffective. Application of different solvents and changing the reaction temperature did not result in formation of product 10. Difficulties in formation of salt 10 make the selected synthetic strategy unsuccessful.
Searching for another method of synthesis of compounds 3 we envisaged a more reliable procedure involving amination of 3-chloro-5,6-diphenyl-1,2,4-triazine (7b) with (oxazol-2-yl)pyridin-2-amine 1-oxides 12. Thus, the synthesis of ligands of type 3 began with preparation of N-oxide 8 by oxidizing 2-aminopyridine-3-carbonitrile (4) with m-chloroperbenzoic acid in dichloromethane (Scheme 3).

Synthesis of chiral N-oxides 12a–e.
Condensation of N-oxide 8 with aminoalcohols 5a–e yielded the desired 3-(oxazol-2-yl)pyridin-2-amine 1-oxides 12a–e in good yields. The reaction time was controlled to avoid transformation of the products to oxazolines 6 (see Experimental part). The preparation of ligands 3 was first attempted by heating oxides 12a and 12c with 3-chloro-5,6-diphenyl-1,2,4-triazine (7b) in dioxane in the presence of K2CO3 at 95°C. Under these conditions the unexpected respective products 13a and 13c were generated (Scheme 4).

Reaction of N-oxides 12a and 12c with 3-chloro-5,6-diphenyl-1,2,4-triazine (7b).
The N-oxide function strongly activates the amino group in compounds 12, so the substitution of the chlorine atom in 7b can proceed under metal-free conditions. Moreover, the secondary NH group in 3a and 3c is also active enough to react with a second molecule of 3-chlorotriazine 7b to give compounds 13a and 13c. To inhibit the reaction of the initially formed compounds 3a and 3c with 3-chlorotriazine, K2CO3 was eliminated from the reaction mixture. Under base-free conditions at 95°C product 3a was obtained in 22% yield accompanied by undesired compound 14a isolated in the yield of 54% (Table 1, entry 1). When the temperature was lowered to 20°C, no reaction between 12a and 7b occurred (Table 1, entry 2). In DMF at 50°C the expected product 3a and unexpected compound 14a were formed in 15% and 48% yield, respectively (Table 1, entry 3). Under these conditions, N-oxide 12b reacted with chlorotriazine 7b giving compounds 3b and 14b in 10% and 48% respective yields after chromatography (Table 1, entry 4). Chemically pure compounds 3a,b and 14a,b were characterized by several analytical techniques including 1H NMR, 13C NMR, IR, HR MS, which confirmed their structures.
Reactions of N-oxides 12a,b with 3-chloro-5,6-diphenyl-1,2,4-triazine (7b).

| R1 | Substrate | Solvent | Base | Temperature °C | Yield% | ||
|---|---|---|---|---|---|---|---|
| 3 | 14 | ||||||
| 1 | t-Bu | 12a | Dioxane | – | 95 | 22 | 54 |
| 2 | t-Bu | 12a | Dioxane | – | 20 | – | – |
| 3 | t-Bu | 12a | DMF | – | 50 | 15 | 48 |
| 4 | Ph | 12b | DMF | – | 50 | 10 | 48 |
| 6 | Ph | 12b | DMF | N,N-dimethylaniline | 50 | 19 | 51 |
| 7 | Ph | 12b | DMF | m-Nitroaniline | 50 | 24 | 45 |
| 8 | Ph | 12b | DMF | p-Nitroaniline | 50 | 17 | 52 |
Undesirable compounds 14a,b were formed by transformation of initially formed products 3a,b. Since the reaction of (oxazol-2-yl)pyridin-2-amine 1-oxides 12 with 3-chloro-5,6-diphenyl-1,2,4-triazine (7b) is conducted in the absence of base, evolving hydrochloride protonates the nitrogen atom of the oxazoline ring in 3a,b activating these compounds towards nucleophilic attack of chloride ion. This leads to opening of the oxazoline ring giving rise to products 14a,b (Scheme 5).

Formation of compounds 14a,b.
The observed reactivity was confirmed in the reactions of three other (oxazol-2-yl)pyridin-2-amine 1-oxides 12c–e with 3-chloro-5,6-diphenyl-1,2,4-triazine (7b). In each case the formation of two products 3c–e and 14c–e was observed. Attempts to separate the products 3c–e and 14c–e by chromatography failed. They were not isolated in chemically pure form. Formation of 3c–e and 14c–e was shown on the basis of analysis of mass spectra of their mixtures. The ESI HR mass spectrum of a mixture of 3c and 14c shows signals at m/z 453.2039 and m/z 489.1804 corresponding to the values expected for [3c+H]+ and [14c+H]+. The mass spectrum of the mixture of 3d and 14d indicates the presence of ions of m/z 501.2039 and m/z 537.1780 which match the calculated masses of [3d+H]+ and [14d+H]+. Analogously, ions with m/z 501.2036 and m/z 537.1798 are observed for the mixture of 3e and 14e. Their masses are virtually identical with the masses calculated for [3e+H]+ and [14e+H]+.
The cationic activated oxazoline ring-opening process under an attack of nucleophile gained synthetic importance, for example in the synthesis of polymers [20, 21]. To circumvent the problem with conversion of 3 to 14, the use of organic bases in the reaction of 12 with 7b was considered. It was predicted that aliphatic amines such as triethylamine or DABCO can form salts with 3-chlorotriazine 7b, as observed previously [22] and their use was excluded. Therefore, the reaction of 12b and 7b was repeated with 2 equivalents of N,N-dimethylaniline, m-nitroaniline or p-nitroaniline. Unfortunately, no significant improvement in yield of the desired product 3b was achieved. Compound 3b isolated in yield 17–24% was still accompanied by its transformation product 14b (45–52%, Table 1, entry 6, 7, and 8). As can be seen from the results summarized in Table 1, in the reaction of 12b and 7b approximately 70% of the substrates are initially converted to the desired product 3b but about 50% of the product is transformed to the open-chain compound 14b.
Initial study was focused on the screening of ligands 2 and 3 in the copper catalyzed enatioselective nitroaldol reaction. Several aldehydes were treated with nitromethane in the presence of in situ generated complexes of ligands 2 and 3 with Cu(OAc)2·H2O. The reactions were carried out in 2-propanol at room temperature and lead to β-nitro alcohols with moderate to good chemical yield but no enantioselectivity was observed (Table 2). Enantiopure compounds 13c and 14b were also screened in the attempted enantioselective addition of nitromethane to m-nitrobenzaldehyde. The β-nitro alcohols formed in the respective yields of 42% and 56% and were isolated as mixtures of enantiomers, which indicates that the compounds 13c and 14b are also not good enantiomeric catalysts in the nitroaldol reaction (Table 2).
Screening of ligands 2, 3, 13c, and 14b in the catalytic enantioselective Henry reaction.a

| R | Aldehyde | Ligand | Product | Yieldb % | eec % | |
|---|---|---|---|---|---|---|
| 1 | 3-NO2C6H4 | 15a | 2a | 17a | 67 | 7 (S) |
| 2 | 3-NO2C6H4 | 15a | 2c | 17a | 75 | 4 (S) |
| 3 | 3-NO2C6H4 | 15a | 2d | 17a | 79 | rac |
| 4 | 3-NO2C6H4 | 15a | 3b | 17a | 79 | rac |
| 5 | 4-NO2C6H4 | 15b | 3b | 17b | 65 | rac |
| 6 | 2-ClC6H4 | 15c | 3b | 17b | 83 | rac |
| 7 | 2-BrC6H4 | 15c | 3b | 17c | 77 | rac |
| 8 | 3-MeC6H4 | 15d | 3b | 17d | 29 | rac |
| 9 | 2-MeOC6H4 | 15e | 3b | 17e | 49 | rac |
| 10 | 3-NO2C6H4 | 15a | 13c | 17a | 42 | rac |
| 11 | 3-NO2C6H4 | 15a | 14b | 17a | 56 | rac |
aAll reactions were performed on a 0.5 mmol scale with 5 mol% of ligand and 5 mol% of Cu(OAc)2·H2O in 2 mL of 2-propanol at room temperature for 98 h.
bYields of isolated products.
cEnantiomeric excess was checked by HPLC using Chiracel OD-H column.
Conclusion
A new class of chiral compounds 2 with three different heterocyclic rings in their structure have been prepared by employing Pd-catalyzed Buchwald-Hartwig cross-coupling reaction between the enantiopure 3-(4,5-dihydro-1,3-oxazol-2-yl)pyridin-2-amines 6 and 3-bromo-5,6-diphenyl-1,2,4-triazine (7a) as the key step. Two different synthetic routes towards compounds 3 containing N-oxide functionality were investigated: amination of 3-chloro-5,6-diphenyl-1,2,4-triazine with N-protected aminopyridine 1-oxide 9 based on aza-Smiles rearrangementand and amination of 3-chloro-1,2,4-triazine with enantiopure 3-[4-R/Ar-4,5-dihydro-1,3-oxazol-2-yl]pyridine-2-amine 1-oxides 12. The use of the former compound failed due to difficulties in formation of salt 10. The second method encountered problems with unexpected subsequent reactions of initially formed product 3. Under basic conditions, product 3 acts as good nucleophile and undergoes reaction with a second molecule of 7b giving compounds 13. In the experiments carried out in the absence of a base or in the presence of a weak organic base, initially formed product 3 undergoes the oxazoline ring opening leading to compound 14. These new classes of oxazoline ligands 2 and 3 do not exhibit enantio-controlling abilities in the copper catalyzed enantioselective Henry reaction. This result may indicate a different mode of copper complexation with ligands 2 and 3 in comparison to ligands 1. The nitrogen atom of the pyridine ring or the oxygen atom of the N-oxide function can be involved in complexation with the copper ion. The stereogenic center of the complex may be located at some distance of the Lewis acid center and does not have any influence on the stereochemical course of the nitroaldol reaction. This issue needs further explanation and will be discussed in due course.
Experimental
1H and 13C NMR spectra were determined at 400 MHz and 100 MHz, respectively, on a Varian 400 spectrometer. Chemical shifts (δ) are reported in part per million from tetramethylsilane with the solvent resonance as the internal standard. Coupling constants are given as absolute values expressed in Hertz. Mass spectra were obtained by using AMD 604 (AMD Intectra GmbH, Germany) and GC/MS QP 5050 Shimadzu (30 m×0.25 mm ID-BPX 5 0.25 mm) spectrometers. Infrared spectra were obtained by using a Magna FTIR–760 Nicolet apparatus and Shimadzu FT IR Affinity-1 spectrometer. Elemental analyzes were obtained with a Elementar Vario EL III CHNS analyzer. Optical rotation values were measured at room temperature with a Perkin-Elmer polarimeter. The ee values were checked by HPLC (Knauer) analysis by using a chiral stationary phase column (Chiralcel OD-H), and eluting with 2-propanol–hexanes. Thin layer chromatography (TLC) was carried out on aluminium sheets coated with silica gel 60 F254 (Merck). Column chromatography separations were performed by using Merck Kieselgel 60 (0.040-0.060 mm). Solvents were dried and distilled according to standard procedures. 3-Chloro-5,6-diphenyl-1,2,4-triazine [23] and 3-bromo-5,6-diphenyl-1,2,4-triazine [1] were synthesized according to literature procedures.
Synthesis of 2-aminopyridine-3-carbonitrile 1-oxide (8)
A solution of 2-aminopyridine-3-carbonitrile (4, 950 mg, 8 mmol) in dichloromethane (30 mL) was cooled to -10°C and treated dropwise with a solution of m-chloroperbenzoic acid (1656 mg, 9.6 mmol) in dichloromethane (15 mL). The resulting mixture was stirred at -10°C for 3 h and then at room temperature for 20 h. The product was filtered off, washed with ethyl ether and dried undera reduced pressure; yield 88% (950 mg); mp 238–239°C; IR (ZnSe): 3271, 3099, 3076, 3057, 2225, 1620, 1581, 1506, 1446, 1215 cm-1; 1H NMR (CDCl3): δ 8.35 (dd, 1H, J = 1.2 Hz, J = 6.4 Hz), 7.73 (br s, 2H), 7.57 (dd, 1H, J = 1.2 Hz, J = 8.0 Hz), 6.69 (dd, 1H, J = 6.4 Hz, J = 8.0 Hz); 13C NMR (DMSO-d6): δ 152.3, 140.8, 130.9, 115.2, 112.1, 91.3. Anal. Calcd for C6H5N3O (135.12): C, 53.33; H, 3.73; N, 31.10. Found: C, 53.37; H, 3.76; N, 31.16.
Synthesis of 3-cyano-2-[(dimethylamino)methyleneamino]pyridine 1-oxide (9)
2-Aminopyridine-3-carbonitrile 1-oxide (8, 135 mg, 1 mmol) was treated with DMF-DMA (0.4 mL, 3 mmol). The mixture was placed in the ultrasonic bath for 15 min and then stirred at room temperature for 80 h. Next, the suspension was dissolved in CCl4 and the solvent was evaporated. The dissolving-evaporating procedure was repeated five times to obtain analytically pure product 9; yield 92% (175 mg); mp 110–112°C; IR (ZnSe): 2227, 1608, 1570, 1517, 1199, 1109 cm-1; 1H NMR (CDCl3): δ 10.03 (s, 1H), 8.17 (dd, 1H, J = 1.6 Hz, J = 6.8 Hz), 7.41 (dd, 1H, J = 1.6 Hz, J = 7.8 Hz), 6.70 (dd, 1H, J = 6.8 Hz, J = 7.8 Hz), 3.17 (s, 3H), 3.15 (s, 3H); 13C NMR (CDCl3) δ: 156.9, 152.3, 143.1, 131.1, 116.0, 115.1, 106.6, 40.9, 33.9. HRMS (ESI). Calcd for C9H11N4O ([M+H]+): m/z 191.0927. Found: m/z 191.0928.
General procedure for the synthesis of 3-(4,5-dihydro- 1,3-oxazol-2-yl)pyridin-2-amines 6a–d and N-oxides 12a–e
An oven dried two-necked flask was filled with argon and charged with 2-aminopyridine-3-carbonitrile (4, 119 mg, 1 mmol) or 2-aminopyridine-3-carbonitrile 1-oxide (8, 135 mg, 1 mmol), the appropriate amino alcohol (1.5 mmol), and anhydrous chlorobenzene (6 mL). The mixture was heated to 60°C and freshly flame-dried ZnCl2 (27 mg, 20 mol%) was added. The mixture was stirred under reflux for the indicated period of time. The solvent was then removed under reduced pressure and the product was extracted with dichloromethane and purified as described below.
3-[(4S)-4-tert-Butyl-4,5-dihydro-1,3-oxazol-2-yl]pyridine-2-amine (6a)
Compound was prepared from (S)-2-amino-3,3-dimethylbutan-1-ol (176 mg, 1.5 mmol) and 2-aminopyridine-3-carbonitrile after 4 days of heating. The product was isolated by silica gel chromatography (hexane/EtOAc, 5:1) and crystallized from hexanes; yield 69% (151 mg); mp 69°C; [α]D20 = +13.9 (c 0.98, CH2Cl2); IR (ZnSe): 3336, 3155, 2953, 1639, 1616, 1467, 1456, 1261, 773 cm-1; 1H NMR (CDCl3): δ 8.12 (dd, 1H, J = 1.8 Hz, J = 5.2 Hz), 7.90 (dd, 1H, J = 1.8 Hz, J = 7.8 Hz), 6.60 (dd, 1H, J = 5.2 Hz, J = 7.8 Hz), 4.29–4.22 (m, 1H), 4.16–4.07 (m, 1H), 2.95 (br s, 2H), 0.93 (s, 9H); 13C NMR (CDCl3) δ: 162.2, 158.2, 151.0, 137.8, 122.2, 104.7, 67.5, 33.8, 25.8. Anal. Calcd for C12H17N3O (219.28): C, 65.73; H, 7.81; N, 19.16. Found: C, 65.77; H, 7.75; N, 19.07.
3-[(4S)-4-Phenyl-4,5-dihydro-1,3-oxazol-2-yl]pyridine-2-amine (6b)
Compound was prepared from (S)-2-phenylglycinol (105 mg, 1.5 mmol) and 2-aminopyridine-3-carbonitrile after 4 days of heating. The product was isolated by silica gel chromatography (hexane/EtOAc, 3:1) and recrystallized from hexanes; yield 99% (236 mg); mp 70–71°C; [α]D20 = +159.5 (c 1.05, CH2Cl2); IR (ZnSe): 3330, 3152, 2950, 1638, 1614, 1464, 1453, 1260, 771 cm-1; 1H NMR (CDCl3): δ 8.18 (dd, 1H, J = 1.9 Hz, J = 4.8 Hz), 7.99 (dd, 1H, J = 1.9 Hz, J = 7.6 Hz), 7.39–7.35 (m, 2H), 7.32–7.28 (m, 3H), 6.65 (dd, 1H, J = 4.8 Hz, J = 7.6 Hz), 5.45 (dd, 1H, J = 8.3 Hz, J = 10.0 Hz), 4.73 (dd, 1H, J = 8.3 Hz, J = 10.0 Hz), 4.17 (t, 1H, J = 8.3 Hz), amino group protons were exchanged with deuterium; 13C NMR (CDCl3): δ 163.8, 158.3, 151.5, 142.2, 138.2, 128.8, 127.7, 126.5, 112.3, 104.4, 73.7, 70.1. HRMS (ESI). Calcd for C14H14N3O ([M+H]+): m/z 240.1131. Found: m/z 240.1131.
3-[(4S)-4-Isopropyl-4,5-dihydro-1,3-oxazol-2-yl]pyridine-2-amine (6c)
Compound was prepared from (S)-valinol (155 mg, 1.5 mmol) and 2-aminopyridine-3-carbonitrile after 4 days of heating. The product was isolated by silica gel chromatography (hexane/EtOAc, 3:1) and crystallized from hexanes; yield 31% (64 mg); mp 100–101°C; [α]D20 = -8.5 (c 1.03, CH2Cl2); IR (KBr): 3309, 3136, 2954, 2364, 1638, 1577, 1450, 1363, 1258, 1068, 1037 cm-1; 1H NMR (CDCl3): δ 8.11 (dd, 1H, J = 1.9 Hz, J = 4.9 Hz), 7.90 (dd, 1H, J = 1.9 Hz, J = 7.7 Hz), 6.59 (dd, 1H, J = 4.9 Hz, J = 7.7 Hz), 4.34 (dd, 1H, J = 7.9 Hz, J = 9.2 Hz), 4.12–4.06 (m, 1H), 4.02 (t, 1H, J = 7.9 Hz), 1.89 (br s, 2H), 1.81–1.73 (m, 1H), 1.01 (d, 3H, J = 6.7 Hz), 0.93 (d, 3H, J = 6.7 Hz); 13C NMR (CDCl3): δ 162.3, 158.2, 137.8, 112.2, 104.7, 72.9, 69.4, 33.1, 18.9, 18.6. Anal. Calcd for C11H15N3O (205.26): C, 64.37; H, 7.37; N, 20.47. Found: C, 64.39; H, 7.31; N, 20.36.
3-[(4R)-4-Benzyl-4,5-dihydro-1,3-oxazol-2-yl]pyridine-2-amine (6d)
Compound was prepared from (R)-2-amino-3-phenylpropan-1-ol (227 mg, 1.5 mmol) and 2-aminopyridine-3-carbonitrile after 4 days. The product was purified by silica gel chromatography (CH2Cl2/MeOH, 40:1); yield 74% (187 mg), yellow oil; [α]D20 = -23.9 (c 1.39, CH2Cl2); IR (KBr): 3334, 3158, 2949, 1632, 1615, 1459, 1450, 1265, 778 cm-1; 1H NMR (CDCl3): δ 8.14 (dd, 1H, J = 1.8 Hz, J = 4.8 Hz), 7.90 (dd, 1H, J = 1.8 Hz, J = 7.6 Hz), 7.34–7.30 (m, 2H), 7.25–7.21 (m, 3H), 6.60 (dd, 1H, J = 4.8 Hz, J = 7.6 Hz), 4.66–4.60 (m, 1H), 4.32 (dd, 1H, J = 8.0 Hz, J = 8.8 Hz), 4.06 (dd, 1H, J = 8.0 Hz, J = 8.8 Hz), 3.11 (dd, 1H, J = 7.0 Hz, J = 13.6 Hz), 2.78 (dd, 1H, J = 7.0 Hz, J = 13.6 Hz), amino group protons were exchanged with deuterium; 13C NMR (CDCl3): δ 162.8, 158.2, 151.3, 138.0, 137.9, 129.2, 128.5, 126.5, 112.3, 104.6, 70.8, 68.0, 42.1. HRMS (ESI). Calcd for C15H16N3O ([M+H]+): m/z 254.1288. Found: m/z 254.1287.
3-[(4S)-4-tert-Butyl-4,5-dihydro-1,3-oxazol-2-yl]pyridine-2-amine 1-oxide (12a)
Compound was prepared from (S)-2-amino-3,3-dimethylbutan-1-ol (176 mg, 1.5 mmol) and 2-aminopyridine-3-carbonitrile 1-oxide after 60 h of heating. The product was isolated by silica gel chromatography (CH2Cl2/MeOH, 10:1) and crystallized from hexanes; yield 75% (176 mg); mp 128–129°C; [α]D20 = +41.8 (c 1.02, CH2Cl2); IR (KBr): 3320, 3220, 2952, 2870, 1620, 1611, 1446, 1210 cm-1; 1H NMR (CDCl3): δ 8.86 (br s, 2H), 8.20 (dd, 1H, J = 1.6 Hz, J = 6.4 Hz), 7.62 (dd, 1H, J = 1.2 Hz, J = 8.0 Hz), 6.57 (dd, 1H, J = 6.4 Hz, J = 7.6 Hz), 4.32 (dd, 1H, J = 8.4 Hz, J = 9.6 Hz), 4.21–4.11 (m, 2H), 0.94 (s, 9H); 13C NMR (CDCl3): δ 161.0, 150.8, 139.0, 128.4, 110.2, 106.9, 76.3, 68.1, 33.8, 25.8. Anal. Calcd for C12H17N3O2 (235.28): C, 61.26; H, 7.28; N, 17.86. Found: C, 61.28; H, 7.11; N, 17.83.
3-[(4S)-4-Phenyl-4,5-dihydro-1,3-oxazol-2-yl]pyridine-2-amine 1-oxide (12b)
Compound was prepared from (S)-2-phenylglicinol (105 mg, 1.5 mmol) and 2-aminopyridine-3-carbonitrile 1-oxide after 24 h of heating. The product was isolated by silica gel chromatography (CH2Cl2/MeOH, 30:1) and recrystallized from the mixture of hexanes and EtOAc; yield 73% (186 mg); mp 108–109°C; [α]D20 = +257.5 (c 1.04, CH2Cl2); IR (KBr): 3250, 1620, 1540, 1446, 1220 cm-1; 1H NMR (CDCl3): δ 8.76 (br s, 2H), 8.23 (dd, 1H, J = 1.2 Hz, J = 6.4 Hz), 7.70 (dd, 1H, J = 1.2 Hz, J = 8.0 Hz), 7.40–7.27 (m, 5H), 6.61 (dd, 1H, J = 6.4 Hz, J = 8.0 Hz), 5.49 (dd, 1H, J = 8.4 Hz, J = 10.0 Hz), 4.78 (dd, 1H, J = 8.4 Hz, J = 10.0 Hz), 4.22 (t, 1H, J = 8.4 Hz); 13C NMR (CDCl3): δ 162.6, 150.9, 141.6, 139.1, 128.9, 128.0, 127.9, 126.5, 110.4, 106.4, 74.1, 70.2. Anal. Calcd for C14H13N3O2 (255.27): C, 65.87; H, 5.13; N, 16.46. Found: C, 65.93; H, 5.12; N, 16.36.
3-[(4S)-4-Isopropyl-4,5-dihydro-1,3-oxazol-2-yl]pyridine-2-amine 1-oxide (12c)
Compound was prepared from (S)-valinol (155 mg, 1.5 mmol) and 2-aminopyridine-3-carbonitrile 1-oxide after 40 h of heating. The product was isolated by silica gel chromatography (CH2Cl2/MeOH, 30:1) and crystallized from hexanes; yield 62% (137 mg); mp 130–131°C; [α]D20 = +22.0 (c 1.01, CH2Cl2); IR (KBr): 3346, 3228, 2958, 2873, 1643, 1614, 1548, 1446, 1192 cm-1; 1H NMR (CDCl3): δ 8.80 (br s, 2H), 8.18 (dd, 1H, J = 1.6 Hz, J = 6.4 Hz), 7.60 (dd, 1H, J = 1.6 Hz, J = 8.0 Hz), 6.56 (dd, 1H, J = 6.8 Hz, J = 8.0 Hz), 4.39 (dd, 1H, J = 7.6 Hz, J = 9.2 Hz), 4.18–4.06 (m, 2H), 1.87–1.77 (m, 1H), 1.02 (d, 3H, J = 6.8 Hz), 0.94 (d, 3H, J = 6.8 Hz); 13C NMR (CDCl3): δ 161.1, 150.7, 138.9, 127.7, 110.3, 106.8, 72.9, 69.9, 33.0, 18.8, 18.5. Anal. Calcd for C11H15N3O2 (221.25): C, 59.71; H, 6.83; N, 18.99. Found: C, 59.82; H, 6.87; N, 18.93.
3-[(4R)-4-Benzyl-4,5-dihydro-1,3-oxazol-2-yl]pyridine-2-amine 1-oxide (12d)
Compound was prepared from (R)-2-amino-3-phenylpropan-1-ol (227 mg, 1.5 mmol) and 2-aminopyridine-3-carbonitrile 1-oxide after 42 h of heating. The product was isolated by silica gel chromatography (CH2Cl2/MeOH, 20:1) and crystallized from a mixture of hexanes and EtOAc; yield 73% (196 mg); mp 134–135°C; [α]D20 = -77.5 (c 1.02, CH2Cl2); IR (KBr): 3379, 3250, 3040, 2884, 1642, 1614, 1546, 1455, 1194 cm-1; 1H NMR (CDCl3): δ 8.75 (br s, 2H), 8.20 (dd, 1H, J = 1.2 Hz, J = 6.4 Hz), 7.58 (dd, 1H, J = 1.2 Hz, J = 8.0 Hz), 7.33–7.22 (m, 5H), 6.56 (dd, 1H, J = 6.4 Hz, J = 8.0 Hz), 4.67–4.62 (m, 1H), 4.37 (t, 1H, J = 8.4 Hz), 4.11 (dd, 1H, J = 7.6 Hz, J = 8.4 Hz), 3.10 (dd, 1H, J = 6.4 Hz, J = 13.6 Hz), 2.83 (dd, 1H, J = 7.6 Hz, J = 14.0 Hz); 13C NMR (CDCl3): δ 161.7, 150.7, 139.0, 137.5, 129.2, 128.6, 127.8, 126.7, 110.3, 106.6, 71.3, 68.0, 41.8. Anal. Calcd for C15H15N3O2 (269.30): C, 66.90; H, 5.61; N, 15.60. Found: C, 66.91; H, 5.64; N, 15.52.
3-[(4S)-4-Benzyl-4,5-dihydro-1,3-oxazol-2-yl]pyridine-2-amine 1-oxide (12e)
Compound was prepared from (S)-2-amino-3-phenylpropan-1-ol (227 mg, 1.5 mmol) and 2-aminopyridine-3-carbonitrile 1-oxide after 47 h of heating. The product was isolated by silica gel chromatography (CH2Cl2/MeOH, 30:1) and crystallized from a mixture of hexanes and EtOAc; yield 72% (194 mg); mp 134–136°C; [α]D20 = +76.8 (c 0.52, CH2Cl2); IR (KBr): 3385, 3251, 3034, 2893, 1641, 1548, 1454, 1193 cm-1; 1H NMR (CDCl3): δ 8.72 (br s, 2H), 8.15 (d, 1H, J = 6.9 Hz), 7.53 (d, 1H, J = 6.9 Hz), 7.28–7.17 (m, 5H), 6.51 (t, 1H, J = 6.9 Hz), 4.63–4.56 (m, 1H), 4.31 (t, 1H, J = 9.2 Hz), 4.06 (t, 1H, J = 8.0 Hz), 3.04 (dd, 1H, J = 6.8 Hz, J = 13.6 Hz), 2.77 (dd, 1H, J = 6.8 Hz, J = 13.6 Hz); 13C NMR (CDCl3): δ 161.4, 150.4, 138.8, 137.3, 129.0, 128.4, 127.9, 126.4, 110.2, 106.5, 71.0, 67.7, 41.6. HRMS (ESI). Calcd for C15H16N3O2 ([M+H]+): m/z 270.1237. Found: m/z 270.1236.
General procedure for the preparation of ligands 2a–d
An oven-dried three-necked flask was filled with argon and charged with Pd2dba3 (45.8 mg, 10 mol%), Xantphos (57.8 mg, 20 mol%), 3-(oxazol-2-yl)pyridine-2-amine 6a–d (0.6 mmol), 3-bromo-5,6-diphenyl-1,2,4-triazine (7a, 156 mg, 0.5 mmol) and K2CO3 (1.38 g, 10 mmol). Then, the flask was evacuated and backfilled with argon. Dioxane (10 mL) was added trough a septum and the mixture was heated under reflux for the indicated period of time. After cooling, the solid material was filtered off and washed with CH2Cl2. The solvent was evaporated, and the resulting crude product was purified as described below.
5,6-Diphenyl-3-{3-[(4S)-4-tert-butyl- 4,5-dihydro-1,3-oxazol-2-yl]pyridin-2-yl}amino-1,2,4-triazine (2a)
The product was obtained from 3-[(4S)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl]pyridine-2-amine (6a) after 24 h of heating as a yellow solid, purified by column chromatography (CH2Cl2/MeOH, 30:1) and crystallized from ethanol; yield 36% (81 mg); mp 204–206°C; [α]D20 = –1.7 (c 0.54, CH2Cl2); IR (ZnSe): 3057, 2958, 1631, 1610, 1506, 1435, 1390, 1053, 759, 696 cm-1; 1H NMR (CDCl3): δ 12.74 (s, 1H), 8.60 (dd, 1H, J = 1.6 Hz, J = 4.8 Hz), 8.13 (dd, 1H, J = 2.0 Hz, J = 7.6 Hz), 7.65–7.63 (m, 2H), 7.58–7.54 (m, 2H), 7.40–7.29 (m, 6H), 6.99 (dd, 1H, J = 5.2 Hz, J = 8.0 Hz), 4.41–4.36 (m, 1H), 4.27–4.22 (m, 2H), 1.03 (s, 9H); 13C NMR (CDCl3): δ 161.9, 158.0, 155.8, 152.3, 151.9, 151.0, 137.7, 136.0, 135.9, 130.5, 129.9, 129.3, 128.7, 128.4, 128.3, 116.4, 108.6, 76.2, 68.1, 34.0, 25.9. Anal. Calcd for C27H26N6O (450.53): C, 71.98; H, 5.82; N, 18.65. Found: C, 71.81; H, 5.79; N, 18.61.
5,6-Diphenyl-3-{3-[(4S)-4-phenyl-4,5-dihydro-1,3-oxazol-2-yl]pyridin-2-yl}amino-1,2,4-triazine (2b)
The product was obtained from 3-[(4S)-4-phenyl-4,5-dihydro-1,3-oxazol-2-yl]pyridine-2-amine (6b) after 22 h of heating as a yellow solid, purified by column chromatography (CH2Cl2/MeOH, 30:1) and crystallized from ethanol; yield 32% (75 mg); mp 104–105°C; [α]D20 = +212.9 (c 0.51, CH2Cl2); IR (ZnSe): 3026, 2887, 1614, 1504, 1442, 1413, 1350, 1128, 1041, 958, 763, 694 cm-1; 1H NMR (CDCl3): δ 12.38 (s, 1H), 8.62 (dd, 1H, J = 1.8 Hz, J = 4.8 Hz), 8.22 (dd, 1H, J = 1.8 Hz, J = 7.8 Hz), 7.62–7.60 (m, 2H), 7.56–7.41 (m, 2H), 7.40–7.29 (m, 11H), 7.04 (dd, 1H, J = 4.8 Hz, J = 7.8 Hz), 5.61 (dd, 1H, J = 8.4 Hz, J = 10.0 Hz), 4.84 (dd, 1H, J = 8.4 Hz, J = 10.0 Hz), 4.29 (t, 1H, J = 8.4 Hz); 13C NMR (CDCl3): δ 163.2, 158.0, 155.9, 152.4, 152.1, 151.3, 141. 6, 138.1, 135.9, 130.4, 130.0, 129.3, 128.8, 128.7, 128.4, 128.3, 127.7, 126.4, 116.6, 108.5, 73.9, 69.9. HRMS (ESI). Calcd for C29H23N6O ([M+H]+): m/z 471.1928. Found: m/z 471.1921.
5,6-Diphenyl-3-{3-[(4S)-4-isopropyl- 4,5-dihydro-1,3-oxazol-2-yl)pyridin-2-yl]amino-1,2,4-triazine (2c)
The product was obtained from 3-[(4S)-4-isopropyl-4,5-dihydro-1,3-oxazol-2-yl]pyridine-2-amine (6c) after 21 h of heating as a yellow solid, purified by column chromatography (CH2Cl2/MeOH, 30:1) and crystallized from ethanol; yield 35% (76 mg); mp 158–160°C; [α]D20 = +1.5 (c 0.52, CH2Cl2); IR (ZnSe): 2.960, 2926, 2899, 2881, 1643, 1627, 1516, 1442, 1396, 1049, 765, 694 cm-1; 1H NMR (CDCl3): δ 12.65 (s, 1H), 8.59 (dd, 1H, J = 1.9 Hz, J = 4.8 Hz), 8.13 (dd, 1H, J = 1.9 Hz, J = 7.7 Hz), 7.62–7.64 (m, 2H), 7.54–7.56 (m, 2H), 7.40–7.29 (m, 6H), 7.00 (dd, 1H, J = 4.8 Hz, J = 7.7 Hz), 4.46 (dd, 1H, J = 8.2 Hz, J = 9.3 Hz), 4.26–4.20 (m, 1H), 4.13 (t, 1H, J = 8.1 Hz), 1.90–1.82 (m, 1H), 1.14 (d, 3H, J = 6.7 Hz), 1.01 (d, 3H, J = 6.7 Hz); 13C NMR (CDCl3): δ 162.7, 158.8, 156.6, 153.0, 152.7, 151.7, 138.4, 136.7, 136.6, 131.1, 130.6, 129.9, 129.4, 129.0, 128.9, 117.0, 109.2, 73.2, 70.5, 33.5, 19.0, 18.9. Anal. Calcd for C26H24N6O (436.51): C, 71.54; H, 5.54; N, 19.25. Found: C, 71.51; H, 5.61; N, 19.18.
5,6-Diphenyl-3-{3-[(4R)-4-benzyl-4,5-dihydro-1,3-oxazol-2-yl]pyridin-2-yl}amino-1,2,4-triazine (2d)
The product was obtained from 3-[(4R)-4-benzyl-4,5-dihydro-1,3-oxazol-2-yl]pyridine-2-amine (6d) after 18 h of heating as a yellow solid, purified by column chromatography (CH2Cl2/MeOH, 30:1) and crystallized from ethanol; yield 37% (89 mg); mp 168–170°C; [α]D20 = -24.6 (c 0.53, CH2Cl2); IR (ZnSe): 3061, 2887, 1643, 1604, 1496, 1440, 1411, 1346, 1047, 767, 694 cm-1; 1H NMR (CDCl3): δ 12.38 (s, 1H), 8.58 (dd, 1H, J = 1.8 Hz, J = 5.0 Hz), 8.12 (dd, 1H, J = 1.8 Hz, J = 7.8 Hz), 7.63–7.58 (m, 2H), 7.57–7.56 (m, 2H), 7.44–7.24 (m, 9H), 7.21–7.17 (m, 2H), 7.00 (dd, 1H, J = 5.0 Hz, J = 7.6 Hz), 4.79–4.71 (m, 1H), 4.41 (t, 1H, J = 8.2 Hz), 4.16 (t, 1H, J = 8.2 Hz), 3.25 (dd, 1H, J = 6.8 Hz, J = 14.0 Hz), 2.87 (dd, 1H, J = 6.8 Hz, J = 14.0 Hz); 13C NMR (CDCl3): δ 162.4, 158.0, 156.0, 152.3, 152.1, 151.1, 137.9, 137.5, 136.0, 135.9, 130.4, 130.0, 129.3, 128.8, 128.6, 128.4, 128.3, 126.6, 116.6, 108.6, 71.1, 67.9, 41.7. HRMS (ESI). Calcd for C30H25N6O ([M+H]+): m/z 485.2084. Found: m/z 485.2088.
Procedure for the reaction of 3-chloro-5,6-diphenyl-1,2,4-triazine (7b) with (4,5-dihydro-1,3-oxazol-2-yl)pyridine-2-amine 1-oxides in the presence of K2CO3
A mixture of 3-chloro-5,6-diphenyl-1,2,4-triazine (7b, 267 mg, 1 mmol), appropriate [4,5-dihydro-1,3-oxazol-2-yl]pyridine-2-amine 1-oxide (1.1 mmol), and K2CO3 (415 mg, 3 mmol) were placed in round-bottom flask. Then, freshly dried dioxane (16 mL) was added and the mixture was heated at 95°C for 24 h. After cooling, the solid material was filtered off and washed with CH2Cl2. The solvent was evaporated, and the resulting crude product was purified as described below.
2-[Bis(5,6-diphenyl-1,2,4-triazin-3-yl)amino]-3-[(4S)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl]pyridine 1-oxide (13a)
Compound was prepared from 3-[(4S)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl]pyridine-2-amine 1-oxide (12a, 259 mg, 1.1 mmol), purified by silica gel chromatography (dichloromethane/methanol, 30:1) and crystallized from hexanes/EtOAc; yield 35% (61 mg); mp 134–136°C; [α]D20 = -17.0 (c 0.61, CH2Cl2); IR (KBr): 3059, 2956, 2868, 1651, 1517, 1490, 1398, 1365, 1280, 1062, 769, 696 cm-1; 1H NMR (CDCl3): δ 8.43 (dd, 1H, J = 1.6 Hz, J = 6.8 Hz), 7.95 (dd, 1H, J = 1.6 Hz, J = 4.8 Hz), 7.54–7.47 (m, 9H), 7.41–7.32 (m, 10H), 7.24–7.19 (m, 2H), 4.15 (dd, 1H, J = 8.6 Hz, J = 10.0 Hz), 3.98 (t, 1H, J = 8.6 Hz), 3.85 (dd, 1H, J = 8.6 Hz, J = 10.0 Hz), 0.61 (s, 9H); 13C NMR (CDCl3): δ 159.0, 158.9, 158.1, 156.7, 156.6, 153.9, 145.8, 141.1, 135.7, 135.6, 135.5, 135.4, 130.5, 130.4, 130.1, 130.0, 129.4, 129.1, 129.0, 128.4, 128.1, 127.2, 126.9, 124.0, 76.8, 33.6, 25.6. HRMS (ESI). Calcd for C42H36N9O2 ([M+H]+): m/z 698.2986. Found: m/z 698.2995.
2-[Bis(5,6-diphenyl-1,2,4-triazin-3-yl)amino]-3-[(4S)-4-isopropyl-4,5-dihydro-1,3-oxazol-2-yl]pyridine 1-oxide (13c)
Compound was prepared from 3-[(4S)-4-isopropyl-4,5-dihydro-1,3-oxazol-2-yl]pyridine-2-amine 1-oxide (12c) (243 mg, 1.1 mmol), purified by silica gel chromatography (CH2Cl2/MeOH, 30:1) and crystallized from hexanes/EtOAc; yield 42% (143 mg); mp 142–144°C; [α]D20 = -21.8 (c 0.61, CH2Cl2); IR (KBr): 3057, 2958, 1651, 1519, 1489, 1398, 1367, 1282, 1064, 759, 696 cm-1; 1H NMR (CDCl3): δ 8.43 (dd, 1H, J = 1.2 Hz, J = 6.8 Hz), 7.95 (dd, 1H, J = 1.2 Hz, J = 8.8 Hz), 7.54–7.47 (m, 9H), 7.40–7.33 (m, 10H), 7.24–7.20 (m, 2H), 4.19 (t, 1H, J = 7.6 Hz), 3.94–3.85 (m, 2H), 1.52–145 (m, 1H), 0.64 (d, 3H, J = 6.8 Hz), 0.60 (d, 3H, J = 6.8 Hz); 13C NMR (CDCl3): δ 159.0, 158.9, 158.3, 156.7, 156.6, 153.9, 153.8, 145.7, 141.2, 135.6, 135.5, 135.4, 130.5, 130.4, 130.1, 130.0, 129.4, 129.3, 129.2, 129.1, 128.4, 128.2, 128.1, 127.2, 126.8, 123.9, 72.9, 70.0, 32.4, 18.3, 18.0. HRMS (ESI). Calcd for C41H34N9O2 ([M+H]+): m/z 684.2830. Found: m/z 684.2836.
Procedure for the reaction of 3-chloro-5,6-diphenyl-1,2,4-triazine (7b) with (4,5-dihydro-1,3-oxazol-2-yl)pyridine-2-amine 1-oxides in the absence of K2CO3
The mixture of 3-chloro-5,6-diphenyl-1,2,4-triazine (7b, 267 mg, 1 mmol) and 3-[(4S)-4-alkyl/aryl-4,5-dihydro-1,3-oxazol-2-yl]pyridine-2-amine 1-oxide (12a or 12b, 1.1 mmol) in DMF (7 mL) was heated at 50°C for 24 h. The solvent was evaporated under vacuum and the products were isolated by silica gel chromatography (CH2Cl2/MeOH, 30:1).
2-(5,6-Diphenyl-1,2,4-triazin-3-ylamino)-3-[(4S)-4-tert-butyl- 4,5-dihydrooxazol-2-yl]pyridine 1-oxide (3a)
Compound was prepared from 3-[(4S)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl]pyridine-2-amine 1-oxide (12a, 259 mg, 1.1 mmol); yield 15% (105 mg); mp 98–100°C; [α]D20 = -30.1 (c 1.27, CH2Cl2); IR (SnZe): 3061, 2955, 1645, 1504, 1360, 1190, 1058, 696 cm-1; 1H NMR (CDCl3): δ 10.59 (br s, 1H), 8.40 (dd, 1H, J = 1.2 Hz, J = 6.4 Hz), 7.81 (dd, 1H, J = 1.2 Hz, J = 8.0 Hz), 7.55–7.51 (m, 4H), 7.40–7.29 (m, 6H), 7.08 (dd, 1H, J = 6.4 Hz, J = 8.0 Hz), 4.05–4.03 (m, 2H), 3.75 (t, 1H, J = 9.4 Hz), 0.83 (s, 9H); 13C NMR (CDCl3): δ 160.1, 156.8, 155.7, 152.6, 144.7, 139.9, 135.5, 135.3, 130.6, 129.9, 129.3, 128.9, 128.4, 128.3, 127.6, 118.1, 117.1, 75.8, 68.9, 33.6, 25.8. HRMS (ESI). Calcd for C27H27N6O2 ([M+H]+): m/z 467.2190. Found m/z 467.2190.
2-(5,6-Diphenyl-1,2,4-triazin-3-ylamino)-3-[(4S)-4-phenyl-4,5-dihydrooxazol-2-yl]pyridine 1-oxide (3b)
Compound was prepared from 3-[(4S)-4-phenyl-4,5-dihydro-1,3-oxazol-2-yl]pyridine-2-amine 1-oxide (12b, 279 mg, 1.1 mmol); yield 10% (29 mg); mp 114–115°C; [α]D20 = -16.2 (c 0.49, CH2Cl2); IR (SnZe): 3059, 2918, 1643, 1600, 1579, 1487, 1390, 1193, 1060, 694 cm-1; 1H NMR (DMSO-d6): δ 10.01 (br s, 1H), 8.59 (dd, 1H, J = 1.4 Hz, J = 6.4 Hz), 7.85 (dd, 1H, J = 1.4 Hz, 8.0 Hz), 7.46–7.36 (m, 7H), 7.33–7.32 (m, 4H), 7.24–7.21 (m, 3H), 7.11–7.09 (m, 2H), 5.22 (dd, 1H, J = 8.8 Hz, J = 10.4 Hz), 4.61 (dd, 1H, J = 8.8 Hz, J = 10.4 Hz), 3.76 (t, 1H, J = 8.8 Hz); 13C NMR (CDCl3): δ 161.8, 156.8, 156.0, 152.9, 144.3, 141.1, 139.5, 135.3, 135.1, 130.8, 129.8, 129.3, 129.1, 128.7, 128.4, 128.3, 128.1, 127.6, 126.4, 118.0, 74.5, 69.8. HRMS (ESI). Calcd for C29H23N6O2 ([M+H]+): m/z 487.1877. Found: m/z 487.1880.
3-[(2S)-1-Chloro-3,3-dimethylbutan-2-ylcarbamoyl]-2-(5,6-diphenyl-1,2,4-triazin-3-ylamino)pyridine 1-oxide (14a)
Compound was prepared from 3-[(4S)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl]pyridine-2-amine 1-oxide (12a, 259 mg, 1.1 mmol); yield 48% (255 mg); mp 128–130°C; [α]D20 = +11.9 (c 0.65, CH2Cl2); IR (SnZe): 3059, 2964, 1660, 1573, 1504, 1479, 1242, 1060, 696 cm-1; 1H NMR (CDCl3): δ 9.89 (br s, 1H), 8.36 (d, 1H, J = 6.4 Hz), 7.76 (d, 1H, J = 7.6 Hz), 7.52–7.51 (m, 2H), 7.40–7.27 (m, 8H), 7.13–7.09 (m, 2H), 4.16–4.03 (m, 1H), 3.65 (dd, 1H, J = 3.6 Hz, J = 11.6 Hz), 3.46 (dd, 1H, J = 4.8 Hz, 12.0 Hz), 0.84 (s, 9H); 13C NMR (CDCl3): δ 157.7, 157.6, 153.3, 142.4, 138.9, 135.4, 134.9, 130.9, 130.0, 129.2, 129.1, 128.6, 128.4, 128.3, 128.3, 119.7, 58.4, 45.1, 35.1, 26.9. HRMS (ESI). Calcd for C27H28N6O2Cl ([M+H]+): m/z 503.1957. Found: m/z 503.1952.
3-[(S)-2-Chloro-1-phenylethylcarbamoyl]-2-(5,6-diphenyl-1,2,4-triazin-3-ylamino)pyridine 1-oxide (14b)
Compound was prepared from 3-[(4S)-4-phenyl-4,5-dihydro-1,3-oxazol-2-yl]pyridine-2-amine 1-oxide (12b, 279 mg, 1.1 mmol); yield 48% (260 mg); mp 157–158°C; [α]D20 = +31.5 (c 0.5, CH2Cl2); IR (SnZe): 3059, 1651, 1575, 1504, 1483, 1386, 1244, 1062, 694 cm-1; 1H NMR (DMSO-d6): δ 9.98 (br s, 1H), 9.15 (d, 1H, J = 8.8 Hz), 8.56 (dd, 1H, J = 1.6 Hz, J = 6.4 Hz), 7.57 (dd, 1H, J = 1.6 Hz, J = 8.0 Hz), 7.43–7.34 (m, 9H), 7.33–7.27 (m, 4H), 7.21–7.15 (m, 3H), 5.18–5.07 (m, 1H), 3.71–3.69 (m, 2H); 13C NMR (CDCl3): δ 164.1, 157.2, 157.1, 153.5, 142.5, 138.8, 137.9, 135.3, 134.7, 131.0, 130.0, 129.4, 129.2, 128.8, 128.7, 128.4, 128.3, 128.2, 126.6, 126.4, 119.0, 54.5, 47.2. HRMS (ESI). Calcd for C29H24N6O2Cl ([M+H]+): m/z 523.1643. Found: m/z 523.1642.
General procedure for the catalytic enantioselective Henry reaction
A mixture of Cu(OAc)2·H2O (5 mg, 0.025 mmol, 5 mol%) and ligand (0.025 mmol, 5 mol%) in anhydrous 2-propanol (2 mL) was stirred at room temperature for 4 h under argon atmosphere to give a red-brown solution. The aldehyde (0.5 mmol) and the nitromethane (270 μL, 5 mmol) were added and the mixture was stirred at room temperature for 4 days. Than the solvent was evaporated under reduced pressure and the product was isolated by column chromatography. All spectroscopic data of the nitroaldol adducts were in good agreement with those reported previously [1].
Acknowledgments
The author is grateful to Prof. Andrzej Rykowski for helpful discussions.
References
[1] Wolińska, E. Chiral oxazoline ligands containing a 1,2,4-triazine ring and their application in the Cu-catalyzed asymmetric Henry reaction. Tetrahedron2013, 69, 7269–7278.10.1016/j.tet.2013.06.084Search in Google Scholar
[2] Wolińska, E. Asymmetric Henry reactions catalyzed by copper(II) complexes of chiral 1,2,4-triazine-oxazoline ligands: the impact of substitution in the oxazoline ring on ligand activity. Tetrahedron: Asymmetry2014, 25, 1122–1128.10.1016/j.tetasy.2014.06.019Search in Google Scholar
[3] Wolińska, E. A study of chiral oxazoline ligands with a 1,2,4-triazine and other six-membered aza-heteroaromatic rings and their application in Cu-catalysed asymmetric nitroaldol reactions. Tetrahedron: Asymmetry2014, 25, 1478–1487.10.1016/j.tetasy.2014.10.001Search in Google Scholar
[4] Karczmarzyk, Z.; Wolińska, E.; Fruziński, A. N-{2-[(4S)-4-tert-Butyl-4,5-dihydro-1,3-oxazol-2-yl]phenyl}-5,6-diphenyl-1,2,4-triazin-3-amine. Acta Cryst.2011, E67, o651.10.1107/S1600536811005411Search in Google Scholar
[5] Coeffard, V.; Müller-Bunz, H.; Guiry, P. J. The synthesis of new oxazoline-containing bifunctional catalysts and their application in the addition of diethylzinc to aldehydes. Org. Biomol. Chem.2009, 7, 1723–1734.10.1039/b822580jSearch in Google Scholar
[6] Charushin, V. N.; Alekxeev, S. G.; Chupakhin, O. N.; Van der Plas, H. C. Behavior of monocyclic 1,2,4-triazines in reactions with C-, N-, O-, and S-nucleophiles. In Advances in Heterocyclic Chemistry. Katritzky, A. R., Ed. Academic Press, Inc.: New York, 1989; Vol. 46, pp 73–142.10.1016/S0065-2725(08)60797-7Search in Google Scholar
[7] Wolińska, E. A convenient method of preparation of 3,3′-dichloro-5,5′-bi-1,2,4-triazine and its synthetic application. Heterocycles2009, 78, 623–633.10.3987/COM-08-11535Search in Google Scholar
[8] Nyffenegger, C.; Fournet, G.; Joseph, B. Synthesis of 3-amino-5H-pyrrolo[2,3-e]-1,2,4-triazines by Sonogashira/copper(I)-catalyzed heteroannulation. Tetrahedron Lett.2007, 48, 5069–5072.10.1016/j.tetlet.2007.05.090Search in Google Scholar
[9] Pellegatti, L.; Vedrenne, E.; Leger, J.-M.; Jarry, C.; Routier, S. First efficient palladium-catalyzed aminations of pyrimidines, 1,2,4-triazines and tetrazines by original methyl sulfur release. Synlett2009, 2137–2142.10.1002/chin.200952177Search in Google Scholar
[10] Yang, B. H.; Buchwald, S. L. Palladium-catalyzed amination of aryl halides and sulfonates. J. Organomet. Chem. 1999, 576, 125–146.10.1016/S0022-328X(98)01054-7Search in Google Scholar
[11] Hartwig, J. F. Discovery and understanding of transition-metal-catalyzed aromatic substitution reactions. Synlett2006, 17, 1283–1294.10.1055/s-2006-939728Search in Google Scholar
[12] Hartwig, J. F. Evolution of a fourth generation catalyst for the amination and thioetherification of aryl halides. Acc. Chem. Res. 2008, 41, 1534–1544.10.1021/ar800098pSearch in Google Scholar
[13] Surry, D. S.; Buchwald, S. L. Biaryl phosphane ligands in palladium-catalyzed amination. Angew. Chem., Int. Ed.2008, 47, 6338–6361.10.1002/anie.200800497Search in Google Scholar
[14] Surry, D. S.; Buchwald, S. L. Dialkylbiaryl phosphines in Pd-catalyzed amination: a user’s guide. Chem. Sci. 2011, 2, 27–50.10.1039/C0SC00331JSearch in Google Scholar
[15] Fujisawa, T.; Ichiyanagi, T.; Shimizu, M. Enantioselective Diels-Alder reaction using chiral Lewis acid prepared from Grignard reagent and a chiral 2-(2-p-toluenesulfonylamino)phenyl-4-phenyloxazoline. Tetrahedron Lett. 1995, 36, 5031–5034.10.1016/00404-0399(50)0914X-Search in Google Scholar
[16] Radel, R. J.; Keen, B. T.; Wong, C.; Paudler, W. W. Syntheses, carbon-13 and proton nuclear magnetic resonance spectra of some 1,2,4-triazine 1- and 2-oxides. J. Org. Chem.1977, 42, 546–550.10.1021/jo00423a033Search in Google Scholar
[17] Gant, T. G.; Meyers, A. I. The chemistry of 2-oxazolines. Tetraherdon1994, 50, 2297–2360.10.1016/S0040-4020(01)86953-2Search in Google Scholar
[18] Wolińska, E. Sequential amination of heteroaromatic halides with aminopyridine 1-oxides and their N-protected derivatives based on novel aza-Smiles rearrangement. Heterocycl. Commun.2012, 18, 227–232.10.1515/hc-2012-0139Search in Google Scholar
[19] Wolińska, E.; Pucko, W. Diversity of reactions of isomeric aminopyridine N-oxides with chloronitropyridines: an experimental and theoretical study. J. Heterocyclic Chem., 2013, 50, 590–598.10.1002/chin.201347137Search in Google Scholar
[20] Wu, W.; Cui, S.; Li, Z.; Liu, J.; Wang, H.; Wang, X.; Zhang, Q.; Wu, H.; Guo. K. Mild Brønsted acid initiated controlled polymerizations of 2-oxazoline towards one-pot synthesis of novel double-hydrophilic poly(2-ethyl-2-oxazoline)-block-poly(sarcosine). Polym. Chem. 2015, 6, 2970–2976.10.1039/C5PY00256GSearch in Google Scholar
[21] Wilsens, C. H. R. M.; Wullems, N. J. M.; Gubbels, E.; Yao, Y.; Rastogic, S.; Noordover, B. A. J. Synthesis, kinetics, and characterization of bio-based thermosets obtained through polymerization of a 2,5-furandicarboxylic acid-based bis(2-oxazoline) with sebacic acid. Polym. Chem. 2015, 6, 2707–2716.10.1039/C4PY01609BSearch in Google Scholar
[22] Rykowski, A. Synthesis of 1,2,4-triazin-3-yltrimethylammonium chlorides and 3-methanesulfonyl-1,2,4-triazines. Pol. J. Chem.1983, 57, 631–635.Search in Google Scholar
[23] Laakso, P. V.; Robinson, R.; Vandrewala, H. P. Studies in the triazine series including a new synthesis of 1, 2, 4-triazines. Tetrahedron1957, 1, 103–118.10.1016/0040-4020(57)85014-5Search in Google Scholar
©2016 by De Gruyter
This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Articles in the same Issue
- Frontmatter
- Preliminary Communication
- A facile one-pot synthesis of aryl-substituted fused pyrimidinones
- Research Articles
- Three-component synthesis of new o-hydroxyphenyl-substituted pyrazolo[3,4-b]pyridines promoted by FeCl3
- Reactions of ferrocenyl chalcones with hydrazines and active methylene compounds
- Synthesis of 3-alkyl-5-allylamino-2-benzoylimino-1,3,4-thiadiazoles via Dimroth rearrangement
- Chiral oxazoline ligands with two different six-membered azaheteroaromatic rings – synthesis and application in the Cu-catalyzed nitroaldol reaction
- Stereoselective Michael addition of O-nucleophiles to carbohydrate-based nitro-olefin
- The synthesis of hydrophobic 1-alkyl-1H,1′H-2,2′-bibenzo[d]imidazoles
- Novel synthesis and reactions of pyrazolyl-substituted tetrahydrothieno[2,3-c]isoquinoline derivatives
- Acid-base properties and keto-enol equilibrium of a 5-substituted derivative of 1,3-diethyl-2-thiobarbituric acid
Articles in the same Issue
- Frontmatter
- Preliminary Communication
- A facile one-pot synthesis of aryl-substituted fused pyrimidinones
- Research Articles
- Three-component synthesis of new o-hydroxyphenyl-substituted pyrazolo[3,4-b]pyridines promoted by FeCl3
- Reactions of ferrocenyl chalcones with hydrazines and active methylene compounds
- Synthesis of 3-alkyl-5-allylamino-2-benzoylimino-1,3,4-thiadiazoles via Dimroth rearrangement
- Chiral oxazoline ligands with two different six-membered azaheteroaromatic rings – synthesis and application in the Cu-catalyzed nitroaldol reaction
- Stereoselective Michael addition of O-nucleophiles to carbohydrate-based nitro-olefin
- The synthesis of hydrophobic 1-alkyl-1H,1′H-2,2′-bibenzo[d]imidazoles
- Novel synthesis and reactions of pyrazolyl-substituted tetrahydrothieno[2,3-c]isoquinoline derivatives
- Acid-base properties and keto-enol equilibrium of a 5-substituted derivative of 1,3-diethyl-2-thiobarbituric acid